Institution profile

医療法人恵聖会 恵聖会クリニック心斎橋院

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01E1907022 +4

Location

Prefecture
Osaka
Address
大阪市中央区東心斎橋1-7-30 21心斎橋ビル8F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 安全未来特定再生医療等委員会
  • 安全未来特定認定再生医療等委員会
  • 医療法人清悠会認定再生医療委員会

Public score

58.5/ 100

A · Review level
25.0 / 30
B · Technologies
20.6 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
5.8 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 222of 1736

Registered technologies
5
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 58.5
Public score →100

Registered technologies (5)

Stem cells (all sources) 5
Registered technologies · Japanese originalTechnology areasPlan classification
慢性疼痛に対する自己脂肪由来間葉系幹細胞を用いた静脈注射治療Stem cells (all sources)Adipose-derived stem cellsClass II
ざ瘡瘢痕に対する自己脂肪由来間葉系幹細胞を用いた静脈注射治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
皮膚の加齢性変化に対しての自己脂肪由来間葉系幹細胞を用いた局所注射療法Stem cells (all sources)Adipose-derived stem cellsSkinClass II
SVF(Stromal Vascular Fraction)を用いた皮下軟部組織治療Stem cells (all sources)Class III
SVF(Stromal Vascular Fraction)を用いた頭髪改善治療Stem cells (all sources)Class III
Adipose-derived stem cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
慢性疼痛に対する自己脂肪由来間葉系幹細胞を用いた静脈注射治療Stem cells (all sources)Adipose-derived stem cellsClass II
ざ瘡瘢痕に対する自己脂肪由来間葉系幹細胞を用いた静脈注射治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
皮膚の加齢性変化に対しての自己脂肪由来間葉系幹細胞を用いた局所注射療法Stem cells (all sources)Adipose-derived stem cellsSkinClass II
Skin 2
Registered technologies · Japanese originalTechnology areasPlan classification
ざ瘡瘢痕に対する自己脂肪由来間葉系幹細胞を用いた静脈注射治療Stem cells (all sources)Adipose-derived stem cellsSkinClass II
皮膚の加齢性変化に対しての自己脂肪由来間葉系幹細胞を用いた局所注射療法Stem cells (all sources)Adipose-derived stem cellsSkinClass II

Certified committee for regenerative medicine

  • 安全未来特定再生医療等委員会
  • 安全未来特定認定再生医療等委員会
  • 医療法人清悠会認定再生医療委員会

Public document number

  • 01E1907022
  • 01E1909029
  • 01E2504001
  • 01E2108011
  • 01E2108013
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
皮膚の加齢性変化に対しての自己脂肪由来間葉系幹細胞を用いた局所注射療法Class II安全未来特定再生医療等委員会01E1907022
ざ瘡瘢痕に対する自己脂肪由来間葉系幹細胞を用いた静脈注射治療Class II安全未来特定認定再生医療等委員会01E1909029
慢性疼痛に対する自己脂肪由来間葉系幹細胞を用いた静脈注射治療Class II安全未来特定認定再生医療等委員会01E2504001
SVF(Stromal Vascular Fraction)を用いた皮下軟部組織治療Class III医療法人清悠会認定再生医療委員会01E2108011
SVF(Stromal Vascular Fraction)を用いた頭髪改善治療Class III医療法人清悠会認定再生医療委員会01E2108013

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor